Robert Glass
@Catalyst Capital Advisors Llc
Latest period2024 - Q3ReportedManaged Assets$4.441BTotal holdings543
Assets growth rate2.47%Assets growth rate (2-Q avg)3.38%Continuous growth in asset value12 quarters
Portfolio positions
This chart displays the top 10 holdings in Catalyst Capital Advisors Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 543 positions.
Assets under management
The assets under management (AUM) of Catalyst Capital Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 12 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 4.441B in assets, with a quarterly growth rate of 2.47% and a 2-quarter average growth rate of 3.38%. The portfolio is managed by Robert Glass, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
TSMTaiwan Semiconductor Mfg Ltd
| 0.12% | $5.28M 30,400 shares@ $173.67 avg price | Increased 22.59% |
METAMeta Platforms Inc
| 0.12% | $4.902M 8,563 shares@ $572.45 avg price | Increased 24.92% |
TTEKTetra Tech Inc New
| 0.11% | $4.823M 102,260 shares@ $47.17 avg price | Increased 463.08% |
QQQInvesco Qqq Tr
| 0.09% | $3.815M 7,816 shares@ $488.07 avg price | Increased 123.96% |
CSCOCisco Sys Inc
| 0.09% | $3.653M 68,642 shares@ $53.23 avg price | Increased 23.66% |
ATIAti Inc
| 0.08% | $3.173M 47,427 shares@ $66.92 avg price | Increased 12413.73% |
AZNAstrazeneca Plc
| 0.07% | $2.82M 36,199 shares@ $77.92 avg price | Increased 6387.28% |
CRBGCorebridge Finl Inc
| 0.07% | $2.706M 92,790 shares@ $29.16 avg price | Increased 30.7% |
MDTMedtronic Plc
| 0.06% | $2.604M 28,920 shares@ $90.04 avg price | Increased 12.1% |
TAKTakeda Pharmaceutical Co Ltd
| 0.06% | $2.531M 178,000 shares@ $14.22 avg price | Increased 7.23% |